HalioDx's Series B Round

HalioDx raised a round of funding on January 17, 2018.

HalioDx is an immuno-oncology diagnostic company providing oncologists with immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno…

Articles about HalioDx's Series B Round: